CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 81 enrolled
Drug / intervention
Alert +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05986695
NCT05986695N/ACompleted

Preliminary Implementation of an Informational Nudge to Improve Heart Failure Prescribing

VA Office of Research and Development·interventional·Posted Aug 14, 2023·Updated May 1, 2026

In Brief

A clinical study evaluating Alert and Peer comparison report for Heart Failure. Completed, enrolled 81 participants across 1 site.

Detailed Summary

This study addresses a critical gap of care for Veterans with heart failure (HF). Only 1/3 or fewer eligible Veterans are receiving recommended SGLT2 and MRA therapies that save lives and prevents HF hospitalizations. The investigators will compare the effect of clinician directed nudges as strategies to improve the health of Veterans with HF.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesUnited States

Timeline

N/ACompletedFinished
202420252026
First PostedAug 14, 2023
Enrollment StartJun 9, 2023
Primary CompletionOct 31, 2024
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 2.9 years ago

Interventions

Alertbehavioral

Interruptive alert. The prototype alert is in the form of a chart note with evidence-based practice guidelines that will actively display in the clinician's list of daily alerts (like an inbox) that must be cleared daily. It is interruptive because can only be dismissed from the clinician's inbox list after signing the note

Peer comparison reportbehavioral

Clinicians will receive an email describing their recent SGLT2 and MRA prescribing performance relative to their peers.